Glp-1 For Weight Loss: Which Glp-1 Is Best For Weight Loss?

What is Glp-1 For Weight Loss?

GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone in the body, playing a crucial role in regulating blood sugar levels and controlling appetite. When used as a weight-loss medication, GLP-1 works by stimulating the pancreas to release insulin, which helps lower blood sugar after meals. At the same time, GLP-1 suppresses appetite by signaling the brain to reduce hunger and slows the emptying of the stomach, making you feel full for longer periods.

Since its initial use for managing type 2 diabetes in the early 2000s, GLP-1 has gained attention for its weight-loss benefits. Over time, its application expanded to weight management, as research showed that GLP-1 medications could effectively reduce appetite and improve metabolic regulation. Compared to traditional methods like calorie restriction or exercise, GLP-1 medications offer a targeted approach that addresses hormonal imbalances to control hunger, improve insulin sensitivity, and support sustainable weight loss. Clinical studies, such as one published in The Lancet (2021), found that patients using GLP-1 agonists like semaglutide lost an average of 5-10% of their body weight within a year, with some patients seeing even greater reductions, especially when combined with lifestyle changes.

How much weight can I expect to lose with GLP-1 medications?

With GLP-1 medications, most individuals can expect to lose approximately 15–20% of their body weight over several months, depending on the specific medication and individual response. This weight loss is often enhanced when combined with lifestyle changes like a healthy diet and regular exercise. However, results can vary, and it’s important to consult with a healthcare provider to determine the most appropriate treatment plan for your goals. 

How Does GLP-1 Work For Weight Loss? 

GLP-1 works for weight loss through a multi-faceted approach, targeting several mechanisms in the body. When food is consumed, GLP-1 is released from the intestines and enters the bloodstream, where it has a direct impact on the brain, stomach, and pancreas. In the brain, GLP-1 reduces appetite by signaling the hypothalamus to suppress hunger, leading to a decrease in food intake. 

It also slows the process of gastric emptying, meaning food stays in the stomach longer, prolonging the feeling of fullness. GLP-1 stimulates the pancreas to release insulin, which helps regulate blood sugar levels after meals, reducing fat storage. Simultaneously, GLP-1 inhibits the release of glucagon, a hormone that triggers the release of stored glucose from the liver, further supporting the reduction of body fat. 

Collectively, these actions contribute to weight loss by controlling hunger, improving energy utilization, and reducing fat storage. A study published in The Lancet in 2021 found that patients using GLP-1 agonists, such as semaglutide, lost an average of 14.9% of their body weight over 68 weeks, compared to just 2.4% in the placebo group, highlighting the effectiveness of GLP-1 in weight loss (Wilding et al., 2021).

What are the Benefits of Using GLP-1 for Weight Loss?

GLP-1 medications offer several benefits for individuals seeking non-surgical weight loss NYC. These medications work by reducing appetite, increasing feelings of fullness, and slowing gastric emptying, which can significantly help in managing food intake. As a result, GLP-1 treatments can lead to consistent and sustainable weight loss without the need for invasive procedures. Additionally, GLP-1 medications improve insulin sensitivity, regulate blood sugar levels, and reduce fat storage, making them an effective option for people with obesity or those who have underlying conditions such as type 2 diabetes. GLP-1 medications are also well tolerated, with many patients experiencing long-term weight loss results when combined with lifestyle changes such as diet and exercise

Weight Loss Before And After

Which GLP-1 helps you lose the most weight? 

Tirzepatide (Zepbound / Mounjaro) currently shows the highest average weight loss among GLP-1–based treatments, with clinical trials reporting up to 20–22% body weight reduction, while semaglutide (Wegovy) follows closely at around 15–17% over longer treatment periods. These differences are largely due to tirzepatide’s dual action on GLP-1 and GIP pathways, which enhances appetite control and metabolic regulation.

The comparison below outlines how different GLP-1 medications perform based on dosing frequency, time to effect, and average weight reduction observed in clinical studies.

How much do GLP-1 drugs cost, and are they covered by insurance? 

The cost of weight loss injections like semaglutide and tirzepatide can vary significantly depending on your insurance coverage. Many insurance plans may cover GLP-1 medications when prescribed for conditions such as type 2 diabetes, but coverage for weight loss specifically may require additional documentation or prior authorization. Without insurance, GLP-1 medications are among the more expensive weight loss treatments, costing between $900 to $1,400 per month. If prescribed for weight loss (obesity management), the cost may be higher, and insurance coverage may be more limited. 

• Semaglutide (Wegovy / Ozempic): ~$900–$1,349 per month without insurance. Discount programs may reduce costs to ~$149–$299/month. Wegovy is more commonly covered for weight loss, while Ozempic is covered for diabetes treatment.
• Tirzepatide (Mounjaro / Zepbound): ~$1,000–$1,400 per month. Self-pay programs may reduce pricing to ~$299–$449/month. Coverage depends on diagnosis, with broader approval for diabetes compared to weight loss use.
• Liraglutide (Saxenda / Victoza): ~$1,000–$1,400+ depending on dose. Saxenda may be covered under obesity treatment plans, while Victoza is primarily included in diabetes formularies.
• Dulaglutide (Trulicity): Around ~$1,000+ per month. Covered for diabetes management, but not approved for weight loss.
• Exenatide (Byetta / Bydureon): ~$500–$900+ depending on formulation. Coverage is usually limited to diabetes indications.
• Retatrutide (Emerging): Still in clinical trials, with no official pricing available. Based on current market trends, it is expected to fall within the higher cost range of GLP-1–based therapies if approved.
• CagriSema (Emerging): Not yet commercially available. Pricing and insurance coverage details remain unconfirmed, though it is expected to follow similar patterns as existing weekly injectables.

Insurance coverage depends on your plan’s formulary, medical diagnosis, and eligibility criteria. Many plans require prior authorization, especially for weight loss use. Patients paying out-of-pocket may have access to manufacturer savings programs or pharmacy discount options, which can significantly reduce monthly costs.

What are the side effects of GLP‑1 medications? 

GLP-1 medications are well tolerated, but like any medical treatment, they can cause side effects. Most side effects are gastrointestinal and occur during the early phase of treatment, especially when starting the medication or increasing the dose.

Common side effects include:

• Nausea, particularly during the first few weeks as the body adjusts to slower digestion
• Vomiting, more likely at higher doses or during dose escalation
• Diarrhea or loose stools
• Constipation or changes in bowel habits
• Abdominal discomfort or bloating
• Headache or mild dizziness
• Reduced appetite and early fullness, which is part of how the medication works but may feel uncomfortable initially
• Low blood sugar (hypoglycemia), especially when combined with other diabetes medications

These effects are mild to moderate and tend to improve over time as the body adapts.

Less common but possible side effects include:

• Injection-site reactions
• Gastrointestinal irritation
• Fatigue or changes in taste
• Temporary hair thinning (reported in some cases, with limited evidence)

Rare but serious risks may include:

• Pancreatitis (inflammation of the pancreas)
• Gallbladder issues, such as gallstones
• Kidney complications, particularly in cases of dehydration
• Thyroid-related concerns, especially in individuals with a history of medullary thyroid cancer or MEN2

Because of these potential risks, GLP-1 medications should be used under medical supervision, with regular follow-up to monitor response, adjust dosing, and manage any side effects effectively.

How to Choose the Right GLP-1 for You?

Choosing the right GLP-1 medication depends on your individual health profile, weight-loss goals, and treatment preferences, not just which drug produces the highest average results. A more effective approach is to match the medication to your specific needs and long-term goals.

Key factors to consider include:

• Budget and insurance coverage
  Monthly costs vary significantly, especially without insurance. Medications like semaglutide and tirzepatide often exceed $1,000 per month, and coverage depends on your diagnosis and plan eligibility.
• Weight-loss goals
  Your target weight reduction plays an important role in treatment selection. For moderate goals, medications like semaglutide may provide steady and reliable results. For larger weight reduction targets, tirzepatide may offer greater average body weight loss due to its dual mechanism.
• Existing health conditions
  Conditions such as type 2 diabetes, insulin resistance, or PCOS can influence which medication is more appropriate. Some GLP-1–based therapies also provide additional metabolic benefits beyond weight reduction.
• Side effect tolerance
  GLP-1 medications commonly cause gastrointestinal side effects such as nausea, vomiting, or constipation, particularly during the early stages of treatment. Individual tolerance can vary, and dose adjustments may be needed.
• Dosing preference (injection vs oral)
  Most GLP-1 medications are injections taken weekly or daily. However, oral semaglutide is available for those who prefer a non-injectable option. Convenience and adherence are important factors in long-term success.
• Lifestyle compatibility
  Your daily routine, eating patterns, and ability to follow a structured plan can affect how well a medication works. GLP-1 treatments are most effective when combined with consistent lifestyle changes.

Which GLP-1 drug is most effective?

Tirzepatide is currently associated with the highest average weight reduction in clinical studies, followed by semaglutide. However, the “best” option varies based on how your body responds, your medical history, and your treatment goals.

Because GLP-1 medications are prescription therapies, the final decision should be made with a qualified healthcare provider who can evaluate your medical history, assess eligibility, and create a personalized treatment plan.

Who qualifies and not qualifies for GLP‑1 weight‑loss drugs? 

GLP-1 medications are prescribed based on specific weight loss medication eligibility criteria, which are defined by clinical guidelines and FDA-approved indications. These medications are not suitable for everyone and require a medical evaluation to determine whether they are safe and appropriate.

The table below outlines general eligibility and contraindications for GLP-1–based weight loss treatments.

GLP-1 medications should always be prescribed under medical supervision, as eligibility depends on your overall health profile, risk factors, and treatment goals. A healthcare provider will assess your history, current conditions, and prior weight-loss attempts before recommending a personalized treatment plan.

Can I take GLP-1 medications if I have a history of thyroid problems or gallbladder disease?  

If you have a history of thyroid problems or gallbladder disease, it’s important to consult with your healthcare provider before taking GLP-1 medications. For individuals with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia type 2 (MEN 2), GLP-1 medications, particularly semaglutide, are not recommended due to potential risks. Regarding gallbladder disease, while GLP-1 medications are not strictly contraindicated, caution may be necessary, as these medications can sometimes worsen gallbladder issues or contribute to the formation of gallstones in certain individuals. At Dr. Syra Aesthetics and Longevity Institute, Dr. Syra Hanif carefully evaluates your medical history to determine whether GLP-1 treatments are a safe and effective option for you, ensuring a personalized approach to your weight loss journey. 

What happens at your medical weight loss consultation? 

Your visit begins with a medical weight loss consultation or evaluation where Dr. Syra Hanif reviews your full health history, weight history, and previous weight‑loss attempts, along with lifestyle factors such as diet, activity, sleep, and any existing conditions that may influence weight regulation. This assessment includes measurements like BMI, body composition, blood pressure, and may involve lab testing to evaluate metabolic markers, glucose levels, hormones, and lipid profiles to understand underlying influences on your weight and metabolism.

Based on the evaluation, a personalized treatment plan is developed that aligns with your health profile and weight loss goals. This plan can include medical treatments such as FDA‑approved GLP‑1 medications if you’re eligible, as well as tailored guidance on nutrition, physical activity, and behavior change; all designed to support sustainable outcomes rather than short‑term fixes. Dr. Hanif’s approach emphasizes structured lifestyle strategy and clinical oversight to address metabolic health and long‑term weight management.

The consultation also covers expectations for follow‑up care, including progress monitoring, adjustments to medications or lifestyle recommendations, and ongoing supervision to ensure safety and effectiveness. Whether conducted in‑clinic or via telehealth, the focus remains on understanding what has worked or not for you in the past and creating a tailored plan that fits your unique needs under physician guidance.

Medical weight loss consultations are 30–60 minutes, and they aim to give you clarity on your health status, eligibility for prescription therapies, and a clear path forward that integrates both medical and lifestyle support.

What tests or assessments will I need to undergo before starting GLP-1 medications?

Before starting GLP-1 medications, you’ll undergo a thorough medical evaluation, which may include blood tests to assess your BMI, blood pressure, blood glucose levels, lipid profile, hormonal levels, and body composition. Your healthcare provider may also recommend additional tests based on your medical history or current health conditions.

What happens if my consultation shows I don’t qualify for GLP-1 medications?

If your consultation shows you don’t qualify for GLP-1 medications, your healthcare provider will discuss alternative weight loss options and treatments better suited to your health profile and goals, ensuring you receive the most appropriate care for your individual needs.

How to get glp-1 for weight loss? 

GLP-1 medications are prescription treatments, which means they can only be started after a medical evaluation by a licensed healthcare provider. The process is structured and involves eligibility screening, consultation, and ongoing monitoring.

Step 1: Check Eligibility :Before starting treatment, it’s important to confirm that you meet the weight loss medication eligibility criteria, including BMI thresholds (≥30, or ≥27 with weight-related conditions), relevant medical history, and readiness for supervised care. You should also review any contraindications, such as a history of thyroid cancer or pancreatitis, with a healthcare provider.

Step 2: Choose a Provider (Online vs. In-Clinic): You can work with either a telehealth provider or a local in-clinic weight loss program. Many licensed telehealth platforms prescribe GLP-1 medications such as semaglutide (Wegovy/Ozempic) and tirzepatide (Zepbound/Mounjaro) after a clinical evaluation. Prescriptions are sent to a pharmacy or delivered directly to your home.

Step 3: Medical Consultation: During the consultation, your provider conducts a clinical assessment, reviewing your health history, weight-loss goals, and any underlying conditions. In some cases, lab tests or body composition analysis may be recommended before starting treatment.

Step 4: Prescription and Treatment Plan:If you are eligible, your provider will prescribe the appropriate GLP-1 medication and initiate a personalized treatment plan. This may include nutrition guidance, activity recommendations, and lifestyle strategies alongside medication to improve outcomes.

Step 5: Ongoing Monitoring and Adjustments: GLP-1 treatment requires regular follow-up to monitor progress, adjust dosage (dose titration), and manage any side effects. These follow-ups can be done in person or virtually, depending on your provider. Most patients begin treatment within a few days to a couple of weeks, depending on evaluation and prescription processing.

How to get an online prescription for glp-1 medications in nyc? 

In New York City, GLP-1 medications can be prescribed online through a licensed healthcare provider using telehealth services. The process is regulated and requires a medical evaluation before any prescription is issued.

Schedule a Virtual Consultation: Start by booking a telehealth appointment with a provider who is licensed in New York State. Many clinics and digital health platforms in NYC offer virtual consultations specifically for weight loss treatment and GLP-1 therapy.

Complete a Medical Evaluation: During your consultation, your provider will conduct a clinical assessment, reviewing your medical history, weight history, current health status, and any conditions such as type 2 diabetes or hypertension. Lab work may be requested to ensure the treatment is safe and appropriate.

Discuss Treatment Options:If you meet the eligibility criteria, your provider will discuss available GLP-1 medications such as semaglutide (Wegovy/Ozempic) or tirzepatide (Zepbound/Mounjaro), including their benefits, risks, and expected outcomes.

Receive an Online Prescription: If approved, your provider will issue an electronic prescription (e-prescription). This can be sent directly to a local pharmacy in NYC or to a partner pharmacy that delivers medication to your home.

Most patients can complete this process within a few days to a week, depending on consultation availability and whether additional testing is required.